| 1 |
Archer JS, Chang JL.Hirsutism and acne in polycystic ovary syndrome [J]．Best Pract Res Clin Obstet Gynaecol, 2004，18(9):737-754.
|
| 2 |
Wang YH, Chen L, Chen H, et al. Gestational insulin resistance and lipid metabolism in pregnant women with polycystic ovary syndrome [J/CD]．Chin J Obstet Gynecol Pediatr：Electron Ed, 2010，6(4):239-245.
|
| 3 |
Li Y, Fan P, Bai H, et al. PAF－AH activity in patients with PCOS andits correlation with glucose and lipid metabolism research[J]. J Sichuan Univ: Med Ed, 2009，40(6):1066-1070.
|
| 4 |
Wan DH, Fan P, Bai H, et al. Polycystic ovary syndrome patients with platelet－activating factor acetyl hydrolase activity and insulin resistance[J]. Chin J Obstet Gynecol, 2010，45(1):30-34.
|
| 5 |
Dokras A．Cardiovascular disease risk factors in polycystic ovary syndrome[J]．Semin Reprod Med，2008，26(1):39-44.
|
| 6 |
Shaw LJ, Bairey-Merz CN, Azziz R, et al.Postmenopausal women with a history of inegular menses an elevated androgen measurement at high risk for worsening cardiovascular event－free survival: Results from the National Institutes of Health－National Heart，Lung，and Blood Institute sponsored women's ischemia syndrome Evaluation[J]．J Clin Endocrinol Metab，2008，93(4):1276-1284.
|
| 7 |
Shoff R, Kerchner A, Maifeld M, et al.Young obese women with polysystic ovary syndrome have evidence of early coronary atherosclerosis[J]. J Clin Endocrinol Metab，2007，92(12):4609-4614.
|
| 8 |
Xu LZ, Shan D. Polycystic ovary syndrome: A metabolic disorder of systemic disease expression in ovarian [J/CD]．Chin J Obstet Gynecol Pediatr：Electron Ed, 2011, 7(4):407-411.
|
| 9 |
Ovalle F, Azziz R．Insulin resistance，polyeystie ovary syndrome，and type 2 diabete mellitus [J]．Fertil Steril，2002，77(6):1095.
|
| 10 |
Legro RS. Polycystie ovary syndrome and cardiovascular disease：A prematrue association[J]. J Endocr Rev，2003，24(3):302-312.
|
| 11 |
Chen ZJ, Shi YH, Zhao YR, et al.Insulin receptor gene polymorphism in the pathogenesis of polycystic ovary syndrome[J]. Chin J Obstet Gynecol，2004，39:582-585.
|
| 12 |
Jin L, Zhu XM, Luo Q, et al. A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS[J]．Mol Hum Reprod，2006，12:151-155.
|
| 13 |
Korhonen S, Romppanen EL, Hihunen M, et al.Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are associated with polycystic ovary syndrome[J]．Fertil Steril，2003，79:1353-1357.
|
| 14 |
San Millan JL, Corton M, Villuendas G, et al.Association of the polycystic ovary syndrome with genomic variants related to insulin resistancc，type 2 diabetes mellitus, and obesity[J]. J Clin Endocrinol Metab，2004，89:2640-2646.
|
| 15 |
Camps J, Marsillach J, Joven J. The paraoxonases：Role in human diseases and methodological difficulties in measurement[J]. Crit Rev Clin Lab Sci, 2009, 46(2):83-106.
|
| 16 |
Zhang F, Fan P, Bai H, et al. Polycystic ovary syndrome paraoxonase 1 gene －108 C / T polymorphism[J]．J Sichuan Univ：Med Ed, 2011，1(6):24-28.
|
| 17 |
Xita N, Ge Orgiou I, Chatzikyriakidou A, et al.Effect of adiponectin gene polymorphisms on circulating adiponectin and insulin resistance indexes in women with polycystic ovary syndrome[J]．Clin Chem，2005，51:416-423.
|
| 18 |
Xita N, Georgiou I, Tsatsoulis A, et al.A polymorphism in the resistin promoter is associated with body mass index in women with polycystic ovary syndrome[J]．Fertil Steril，2004，82:1466-1467.
|
| 19 |
Shi YH, Sheng Y, Chen ZJ, et al.Resistin gene intron 2 polymorphism with polycystic ovary syndrome research[J]. J Shandong Univ：Med Ed，2005, 43:694-696.
|
| 20 |
Gonzalez A, Abril E, Roca A, et al.Specific CAPN10 gene haplotypes influence the clinical profile of polycystic ovary patients[J]．Clin Endocrinol Metab，2003，88:5529-5536.
|
| 21 |
Guan LX, Ji XW, Wang JX.et al. Plasminogen activator inhibitor－1 gene promoter polymorphism and the Chinese people care about －6754G/5G disease－related research[J]. Chin J Gene，2002，19:393-396.
|
| 22 |
Chu XM, He BX. Plasminogen activator inhibitor－1 gene polymorphisms and metabolic syndrome[J]. J Cardiol，2004，2:184-186.
|
| 23 |
Li N, Cong J, Wu XK, et al.Polycystic ovary syndrome susceptibility gene research[J]．J Med Res，2010，1:122-124.
|
| 24 |
Korhonen S, Heinonen S, Hihunen M, et al.Polymorphism in the peroxisome proliferator－activated receptor gamma gene in women with polycystic ovary syndrome[J]．Hum Reprod，2003，18:540-543.
|
| 25 |
Peral B, San Millan JL, Castello R, et al. Comment: The methionine 196 arginine polymorphism in exon 6 of the TNF receptor 2 gene (TNFRSF1 B)is associated with the polycystic ovary syndrome and hyperandrogenism[J]．J Clin Endocrinol Metab, 2002，87:3977-3983.
|
| 26 |
Kaibe M, Takakuwa K, Murakawa H, et al. Studies on the human leukocyte antigens in patients with polycystic ovary syndrome in a Japanese population：Possible susceptibility of HIA－A11 and DRB1*0403 to patient population with polycystic ovary syndrome[J]．Am J Reprod Immunol，2006，55:301-306.
|
| 27 |
Glueck CJ, Sieve L, Zhu B, et al. Plasminogen activator inhibitor activity，4G 5G polymorphism of the plasminogen activator inhibitor l gene, an d first trimester miscarriage in women with polycystic ovary syndrome[J]．Metabolism，2006，55:345-352.
|
| 28 |
Orion F Jr, Palomba S, Cascella T, et al. Is plasminogen activator inhibitor－1 a cardiovascular risk factor in young women with polycystic ovary syndrom[J]? Reprod Biomed Online，2004，9:505-510.
|
| 29 |
Zhao JL, Chen ZJ, Zhao YR, et al.Plasminogen activator inhibitor－l gene promoter 4G and 5G polymorphism genotype distribution and correlation study of polycystic ovary syndrome[J]．Chin J Obstet Gynecol，2005，40:528-531.
|
| 30 |
Kolbus A, Walch K, Nagele F, et al.Huber Interleu－kin－1 alpha but not interleukin－1beta gene polymorphism is associated with polycystic ovary syndrome [J]．J Reprod Immunol，2006，10(4):1-6.
|